Predictors of unfavorable outcome in neurosyphilis: Multicenter ID-IRI Study.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 13 06 2018
accepted: 12 10 2018
pubmed: 29 10 2018
medline: 22 3 2019
entrez: 29 10 2018
Statut: ppublish

Résumé

Neurosyphilis (NS) has different clinical manifestations and can appear during any stage of syphilis. We aimed to identify the factors affecting poor outcome in NS patients. Patients with positive cerebrospinal fluid Venereal Disease Research Laboratory test, and positive serological serum treponemal or nontreponemal tests were classified as definite NS. The data of 141 patients with definite NS were submitted from 22 referral centers. Asymptomatic NS, syphilitic meningitis, meningovascular syphilis, tabes dorsalis, general paresis, and taboparesis were detected in 22 (15.6%), 67 (47.5%), 13 (9.2%), 10 (7%), 13 (9.2%), and 16 patients (11.3%), respectively. The number of HIV-positive patients was 43 (30.4%). The most common symptoms were headache (n = 55, 39%), fatigue (n = 52, 36.8%), and altered consciousness (50, 35.4%). Tabetic symptoms were detected in 28 (19.8%), paretic symptoms in 32 (22.6%), and vascular symptoms in 39 patients (27.6%). Eye involvement was detected in 19 of 80 patients (23.7%) who underwent eye examination and ear involvement was detected in eight of 25 patients (32%) who underwent ear examination. Crystallized penicillin was used in 109 (77.3%), procaine penicillin in seven (4.9%), ceftriaxone in 31 (21.9%), and doxycycline in five patients (3.5%). According to multivariate regression analysis, while headache was a protective factor in NS patients, double vision was significantly associated to poor outcome. We concluded that double vision indicated unfavorable outcome among NS patients. A high clinical suspicion is needed for the diagnosis NS. As determined in our study, the presence of headache in syphilitic patients can help in early diagnosis of central nervous system disease.

Identifiants

pubmed: 30368740
doi: 10.1007/s10096-018-3403-7
pii: 10.1007/s10096-018-3403-7
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-134

Références

Sex Transm Infect. 2003 Oct;79(5):415-6
pubmed: 14573840
Eur Neurol. 2004;52(1):29-35
pubmed: 15237250
Clin Microbiol Rev. 2006 Jan;19(1):29-49
pubmed: 16418521
Int J Neurosci. 2008 Sep;118(9):1251-7
pubmed: 18698508
Pharmacotherapy. 2010 Apr;30(4):119e-22e
pubmed: 20334461
CNS Neurosci Ther. 2010 Oct;16(5):e157-68
pubmed: 20626434
J Neurol. 2012 Apr;259(4):720-8
pubmed: 21964751
Dermatology. 2013;226(2):148-56
pubmed: 23615173
Braz J Infect Dis. 2013 Sep-Oct;17(5):538-44
pubmed: 23835007
Int J Dermatol. 2014 Jul;53(7):812-9
pubmed: 24261864
Continuum (Minneap Minn). 2014 Aug;20(4 Neuro-ophthalmology):942-65
pubmed: 25099102
Neurology. 2014 Nov 25;83(22):e188-96
pubmed: 25422404
Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26 Suppl A:18A-22A
pubmed: 25798161
Curr Infect Dis Rep. 2015 May;17(5):481
pubmed: 25896752
Clin Med (Lond). 2016 Apr;16(2):184-8
pubmed: 27037391
J Eur Acad Dermatol Venereol. 2016 Nov;30(11):1886-1900
pubmed: 27306850
Clin Infect Dis. 2016 Nov 1;63(9):1180-1186
pubmed: 27585981
BMC Infect Dis. 2017 Jan 10;17(1):51
pubmed: 28068915
Microb Cell. 2016 Jun 27;3(9):363-370
pubmed: 28357375
Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1595-1611
pubmed: 28397100
Emerg Infect Dis. 2018 Feb;24(2):193-200
pubmed: 29350138
JAMA. 1972 Feb;219(6):726-9
pubmed: 5066697
AJNR Am J Neuroradiol. 1995 Apr;16(4):703-11
pubmed: 7611026

Auteurs

Derya Ozturk-Engin (D)

Department of Infectious Diseases and Clinical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey. dr.deryaengin@gmail.com.

Hakan Erdem (H)

Principal Coordinator of ID-IRI, Ankara, Turkey.

Rodrigo Hasbun (R)

Department of Infectious Diseases, UT Health McGovern Medical School, Houston, TX, USA.

Shu-Hua Wang (SH)

Division of Infectious Diseases, Deparment of Internal Medicine, The Ohio State University, Columbus, OH, USA.

Hulya Tireli (H)

Department of Neurology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.

Pierre Tattevin (P)

Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.

Xavier Argemi (X)

Department of Infectious Diseases and Clinical Microbiology, Nouvel Hôpital Civil, Strasbourg, France.

Enora Ouamara-Digue (E)

Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.

Andrea Gombos (A)

Department of Infectious Disease and Clinical Microbiology, Saint Laszlo Hospital Budapest, Budapest, Hungary.

Botond Lakatos (B)

Department of Infectious Disease and Clinical Microbiology, Saint Laszlo Hospital Budapest, Budapest, Hungary.

Fatma Sırmatel (F)

Department of Infectious Disease and Clinical Microbiology, Izzet Baysal University School of Medicine, Bolu, Turkey.

Yasemin Cag (Y)

Department of Infectious Diseases and Clinical Microbiology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.

Abdullah Umut Pekok (AU)

Department of Infectious Diseases and Clinical Microbiology, Private Erzurum Sifa Hospital, Erzurum, Turkey.

Seniha Senbayrak (S)

Department of Infectious Diseases and Clinical Microbiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.

Ilker Inanç Balkan (II)

Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.

Marie Gheno (M)

Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.

Nuray Uzun (N)

Department of Infectious Diseases and Clinical Microbiology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.

Selçuk Kaya (S)

Department of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University School of Medicine, Trabzon, Turkey.

Gönül Cicek-Senturk (G)

Department of Infectious Disease and Clinical Microbiology, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

Gönül Şengöz (G)

Department of Infectious Diseases and Clinical Microbiology, Haseki Training and Research Hospital, Istanbul, Turkey.

Recep Tekin (R)

Department of Infectious Diseases and Clinical Microbiology, Dicle University Faculty of Medicine, Diyarbakır, Turkey.

Mustafa Kemal Çelen (MK)

Department of Infectious Diseases and Clinical Microbiology, Dicle University Faculty of Medicine, Diyarbakır, Turkey.

Saygın Nayman-Alpat (S)

Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

Pınar Ergen (P)

Department of Infectious Diseases and Clinical Microbiology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.

Alper Şener (A)

Department of Infectious Diseases and Clinical Microbiology, Onsekiz Mart University School of Medicine, Canakkale, Turkey.

Canan Agalar (C)

Department of Infectious Diseases and Clinical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.

Sükran Köse (S)

Department of Infectious Diseases and Clinical Microbiology, Tepecik Training and Education Hospital, İzmir, Turkey.

Ahmet Çagkan Inkaya (AÇ)

Department of Infectious Disease and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Figen Kaptan (F)

Department of Infectious Diseases and Clinical Microbiology, Atatürk Training and Research Hospital, İzmir Kâtip Çelebi University, İzmir, Turkey.

Fahad Al-Majid (F)

Department of Medicine, Infectious Diseases Division, King Saud University Hospital, Riyadh, Saudi Arabia.

Umit Savasci (U)

Department of Infectious Diseases and Clinical Microbiology, Gulhane Medical Academy, Ankara, Turkey.

Haluk Vahaboglu (H)

Department of Infectious Diseases and Clinical Microbiology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH